NCT05475314View on ClinicalTrials.gov

Effect of Postbiotic Product on Colonic Barriers in IBS

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2022

Conditions
IBS - Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

ReFerm(R)

Enemas of approx 250 mL twice daily

Trial Locations (1)

58185

Linköping University Hospital, Linköping, Sweden, Linköping

All Listed Sponsors
collaborator

University Hospital, Linkoeping

OTHER

collaborator

Linkoeping University

OTHER_GOV

lead

Nordisk Rebalance A/S

INDUSTRY

NCT05475314 - Effect of Postbiotic Product on Colonic Barriers in IBS | Biotech Hunter | Biotech Hunter